VIROLOGIC OUTCOMES OF LAMIVUDINE/DOLUTEGRAVIR IN VIROLOGICALLY SUPPRESSED SUBJECTS WITH EXPECTED OR CONFIRMED RESISTANCE TO LAMIVUDINE

VOLVER
GESIDA 11820
JOSÉ RAMÓN ARRIBAS LÓPEZ / FEDERICO PULIDO
HOSPITAL UNIVERSITARIO LA PAZ, MADRID / HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, MADRID
22-JUL.-2020
ANALYZING DATA / PUBLISHED
YES
YES
121
120
PUBLISHED